2005 Safety and Availability Communications
This webpage was developed to provide the public with important information about the safety and availability of biological products.
Important Safety Alert: BacT/ALERT BacT/VIEW Users[ARCHIVED] NovoSeven Coagulation Factor VIIa (Recombinant)
- Guillain-Barré Syndrome Among Recipients of Menactra® Meningococcal Conjugate Vaccine --- United States, June--July 2005
FDA and CDC Issue Alert on Menactra Meningococcal Vaccine and Guillain Barre Syndrome[ARCHIVED] DIC following Rho(D) Immune Globulin Intravenous Administration[ARCHIVED] Disseminated Intravascular Coagulation Associated with Acute Hemoglobinemia or Hemoglobinuria following Rho(D) Immune Globulin Intravenous Administration for Immune Thrombocytopenic Purpura(PDF - 68KB) Safety of Albumin Administration in Critically Ill Patients[ARCHIVED] Dear Doctor Letter - Albumin Use in Seriously Ill Patients[ARCHIVED]
- Unapproved Home - Use Diagnostic Kits Marketed by Globus Media
Recall of Rapid HIV Test Kits-Globus Media, Inc[ARCHIVED] FDA Warns Consumers Not to Use Home-Use Diagnostic Kits Marketed by Globus Media - Talkpaper[ARCHIVED] Important Information Relating to Recall of Fetal Cell Screening Kit (FETALSCREEN) - Ortho-Clinical Diagnostics[ARCHIVED] Recall of Fetal Cell Screening Kit (FETALSCREEN) - Ortho-Clinical Diagnostics[ARCHIVED]